MedPath

propofol with ketamine or propofol with etomidate, which one influences the hemodynamic stability lesser?

Phase 2
Conditions
Condition 1: Change in heart rate caused by anesthesia induction. Condition 2: Change in blood pressure caused by anesthesia induction.
Bradycardia, unspecified
Hypotension, unspecified
Registration Number
IRCT201112224731N10
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

to have indication for elective surgeries; to be 50 or over 50 years old. Exclusion criteria: to have indication for emergency surgery; addiction to opiate; pregnancy; patients being treated with sedative or antipsychotic drugs in the past month; to have a personality disorder; to have body weight more than 20% of the ideal body weight for that height and gender; to have contraindication for etomidate, ketamine and propofol

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic blood pressure. Timepoint: Before and immediately after induction, 1 and 3 minutes after intubation. Method of measurement: Non-invasive monitoring device with automatic cuff.;Heart rate. Timepoint: before and immediately after induction, 1 and 3 minutes after intubation. Method of measurement: Continuous ECG monitoring.;Blood O2 saturation. Timepoint: before and immediately after induction, 1 and 3 minutes after intubation. Method of measurement: pulse oximetry.;Diastolic blood pressure. Timepoint: before and immediately after induction, 1 and 3 minutes after intubation. Method of measurement: Non-invasive monitoring device with automatic cuff.;Mean arterial blood pressure. Timepoint: before and immediately after induction, 1 and 3 minutes after intubation. Method of measurement: non-invasive monitoring devices with automatic cuff.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath